Zybio Inc. is a high-tech enterprise specializing in in vitro diagnostic reagents and equipment, headquartered in Chongqing. With over 3,300 global employees, including 30% in R&D, Zybio emphasizes investing at least 15% of sales revenue in research. The company has established multiple R&D centers in China, covering various diagnostic products and core technologies. Zybio operates a 100,000 m² manufacturing plant, with ISO certifications, producing 3.0 billion reagent kits and 35,000 equipment annually. A leading medical equipment enterprise, Zybio’s products are distributed globally, serving over 13,000 hospitals in 100 countries. Their commitment to accuracy and innovation drives ongoing collaboration with medical institutions worldwide.